Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause Focal segmental glomerulosclerosis? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Focal segmental glomerulosclerosis have been filed in association with TACROLIMUS\TACROLIMUS ANHYDROUS. This represents 0.1% of all adverse event reports for TACROLIMUS\TACROLIMUS ANHYDROUS.
5
Reports of Focal segmental glomerulosclerosis with TACROLIMUS\TACROLIMUS ANHYDROUS
0.1%
of all TACROLIMUS\TACROLIMUS ANHYDROUS reports
0
Deaths
2
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From TACROLIMUS\TACROLIMUS ANHYDROUS?
Of the 5 reports, 2 (40.0%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS\TACROLIMUS ANHYDROUS. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause?
Off label use (708)
Death (321)
Transplant rejection (278)
Diarrhoea (257)
Pyrexia (243)
Alopecia (232)
Drug ineffective (198)
Transplant dysfunction (198)
Hospitalisation (194)
Pneumonia (193)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which TACROLIMUS\TACROLIMUS ANHYDROUS Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
TACROLIMUS\TACROLIMUS ANHYDROUS vs TADALAFIL
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB-CXIX